Annals of internal medicine
-
Zampieri FG, Machado FR, Biondi RS, et al. Effect of slower vs faster intravenous fluid bolus rates on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA. 2021;326:830-8. 34547081.
-
Editorial Comment
Extending a Lifeline to Nonhospitalized Patients With COVID-19 Through Automated Text Messaging.
In their article, Delgado and colleagues reported observed outcomes of an automated, text message–based monitoring program with 24/7 clinical support, implemented to monitor nonhospitalized patients with COVID-19. The editorialists discuss the findings and note factors that contributed to the intervention's success.
-
Jiménez D, Agustí A, Tabernero E, et al. Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbation: a randomized clinical trial. JAMA. 2021;326:1277-85. 34609451.
-
Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. JAMA Intern Med. 2021;181:1612-20. 34617959.
-
Comment
In mild acute diverticulitis, outpatient therapy without antibiotics was noninferior to antibiotics.
Mora-López L, Ruiz-Edo N, Estrada-Ferrer O, et al. Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO-study): a multicentre, randomised, open-label, noninferiority trial. Ann Surg. 2021;274:e435-42. 34183510.